In 1995, after finishing his residency, Drebin became an assistant professor of surgery at Washington University School of Medicine.[5] He became an associate professor in 1999, and then a full Professor of Surgery and of Molecular Biology & Pharmacology in 2002.[1] Drebin began working at Penn Medicine in 2004 when he was hired as Chief of the Division of Gastrointestinal Surgery.[6] In 2009, he was named chair of the department.[1][6] While there, he joined a Stand Up to Cancer “Dream Team” against pancreatic cancer as a co-Principal Investigator alongside Craig B. Thompson.[7][8][9] In 2017, Drebin moved to Memorial Sloan Kettering to become Department of Surgery Chair.[1] In addition to his responsibilities as chair, he provides surgical treatments for patients with pancreatic, gallbladder, bile duct, liver, and stomach cancers. His research focuses on the development of new targeted therapies.[1]
Other roles
President, Society of Clinical Surgery (2010–2012)
^Drebin, J. A.; Link, V. C.; Stern, D. F.; Weinberg, R. A.; Greene, M. I. (1 July 1985). "Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies". Cell. 41 (3): 697–706. doi:10.1016/s0092-8674(85)80050-7. ISSN0092-8674. PMID2860972. S2CID26000048.
